MY, AT, TH, ST, RT, KK, YT, KS, NH, KG, and MH have no conflicts of interest to declare. TK received honoraria from CHUGAI PHARMACEUTICAL Co., LTD, Takeda Pharmaceutical Company Limited, ONO Pharmaceutical Co., Eli Lilly and Company, and Taiho Pharmaceutical.

This study was approved by the Ethics Review Committee of NHO Osaka National Hospital (#21106) and conformed to the provisions of the Declaration of Helsinki. The patient provided informed consent.